On April 27, the U.S. Food and Drug Administration approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma in adults. The Alair Bronchial Thermoplasty System is intended for patients whose severe and persistent asthma is not well-controlled with medications. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm209909.htm
FDA approves new device for asthma
The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.